CONSORT diagram: NSABP Protocols B-30, B-31, B-34, and B-38. BC=Breast

Landmark trials in breast cancer.pptx

CONSORT Diagram: NSABP B-36. a QOL sub-study. b MH sub-study. c

Cancers, Free Full-Text

Alterations in immune cell phenotype and cytotoxic capacity in

PDF) CONSORT 2010 Explanation and Elaboration: updated guidelines

Frontiers Triple-negative and Her2-positive breast cancer in

Gemcitabine as adjuvant chemotherapy in patients with high-risk

The impact of anthracyclines in intermediate and high-risk HER2

Comparison of Breast Cancer Recurrence and Outcome Patterns

In the Era After the European Organisation for Research and

CONSORT diagram. AE, adverse event; BC, breast cancer; ddAC, dose

Immunological and clinicopathological features predict HER2

Impact of HER2-low status for patients with early-stage breast